Replies to post #7394 on Revance Therapeutics Inc (RVNC)

[biotech_researcher]

Curious, how large is the Perceptive's purchase?

[alertmeipp]

Seems they are one of the subscribers to the recent offering.
Avg cost: $6.42...
0.05% of their holdings.

Hope they will average down.

[TimelessGoblin26]

Just aggregate the information here. Four bio funds posted new position in RVNC in Q1:
Perceptive Advisors: 600,000 shares
Opaleye Management: 785,000 shares
Tang Capital: 200,000 shares
Stonepine Capital: 1,976,342 shares

Perceptive also holds 5,753,798 shares EOLS, up from 3,963,424 last Q.
Opaleye doesn't own EOLS.
Tang 4,147,399 shares EOLS, up from 3,097,399 last Q.
Stonepine holds 2,674,356 shares EOLS, down from 5,333,004 last Q.